Search

Your search keyword '"Garau, I."' showing total 135 results

Search Constraints

Start Over You searched for: Author "Garau, I." Remove constraint Author: "Garau, I."
135 results on '"Garau, I."'

Search Results

1. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

2. A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade

4. Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo

6. Independència de la deambulació i la defecació en un camp obert poc atemoridor, posada de manifest en un estudi generacional

9. Independència de la deambulació i la defecació en un camp obert poc atemoridor, posada de manifest en un estudi generacional

10. Importància de la recerca amb models animals en el camp de les diferències individuals

11. Extraversió humana i deambulació en rates

12. Investigació en Psicologia experimental i Psicofisiologia a la Secció de Psicologia de la Universitat Autònoma de Barcelona (1979-1983)

14. Abstract P6-17-08: Dynamics of tumor-infiltrating lymphocytes (TILs) during neoadjuvant dual HER2 blockade in HER2-positive (HER2+) breast cancer in the absence of chemotherapy

15. Abstract P6-17-07: Gene signatures and subtype changes during HER2 dual blockade in PAM50 HER2-enriched HER2-positive breast cancer

16. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain

17. Abstract P2-09-14: A predictive model of pathological response following dual HER2 blockade-only based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer

18. Abstract P5-20-19: PAM50 intrinsic subtype predicts survival outcome in HER2-positive/hormone receptor-positive metastatic breast cancer treated with palbociclib and trastuzumab: a correlative analysis of the PATRICIA (SOLTI 13-03) trial

20. SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer

21. Tumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial

22. Abstract OT3-02-07: A phase II study to compare fulvestrant (F) 500mg plus placebo versus (vs) F 500mg plus palbociclib (P) as first line treatment for postmenopausal women with hormone receptor (HR)-positive advanced breast cancer (BC) sensitive to endocrine therapy (ET). “The FLIPPER study” (GEICAM/2014-12)

23. Abstract P5-15-18: MERIBEL STUDY: Single-agent eribulin as first-line therapy for taxane-resistant HER2[-] metastatic breast cancer (MBC) patients (pts)

24. Abstract P6-09-33: CASCADE study: Rapid survival decline per treatment line in metastatic breast cancer

25. Childhood cancer survival in Europe

26. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

27. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century

28. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations

29. MERIBEL study: Single-agent eribulin as first-line therapy for taxane-resistant HER2[-] metastatic breast cancer (MBC) patients (pts)

30. Famosa: Evaluation of a multigene panel in patients with suspected HBOC

31. CASCADE study: pronounced decline in treatment efficacy through the metastatic life of breast cancer patients

32. Abstract P3-07-39: CASCADE study: Treatment and clinical outcomes of metastatic breast cancer by tumor immunophenotypes

33. Abstract P5-08-43: CASCADE study: Longer overall survival inthe novoversus recidivant patients with locally advanced/metastatic breast cancer

35. 1882 CASCADE study: Epidemiological analysis of current natural history and treatment patterns of metastatic breast cancer in spain

37. Adesione alle linee guida per il trattamento dei carcinomi della mammella a stadio limitato in relazione alla spesa sanitaria nazionale totale

38. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States

39. 321TiP - SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer

40. 155PD - Tumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial

41. Compliance with good practice in early breast cancer treatment in relation to total national health expenditure

42. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study

43. Indicators od compliance with guidelines in the EUROCARE-3 High Resolution study on breast cancer

44. Survival from rare cancer in adults: a population-based study

45. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis

46. Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo

Catalog

Books, media, physical & digital resources